EX-99.77B ACCT LTTR

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Trustees of
Nuveen Funds

In planning and performing our audits of the financial statements of
each of the Nuveen Funds listed in Exhibit A attached hereto (the
 Funds ) as of and for the year/period ended May 31, 2013, in
accordance with the standards of the Public Company Accounting
Oversight Board (United States), we considered the Funds internal
control over financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing procedures for the
purpose of expressing our opinion on the financial statements and to
comply with the requirements of Form N-SAR, but not for the
purpose of expressing an opinion on the effectiveness of the Funds
internal control over financial reporting.  Accordingly, we express no
such opinion.

The management of the Funds is responsible for establishing and
maintaining effective internal control over financial reporting. In
fulfilling this responsibility, estimates and judgments by management
are required to assess the expected benefits and related costs of
controls. A funds internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally
accepted accounting principles. A funds internal control over
financial reporting includes those policies and procedures that (1)
pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the
assets of the fund; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the fund are being
made only in accordance with authorizations of management and
trustees of the fund; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use or
disposition of a funds assets that could have a material effect on the
financial statements.

Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements. Also, projections
of any evaluation of effectiveness to future periods are subject to the
risk that controls may become inadequate because of changes in
conditions, or that the degree of compliance with the policies or
procedures may deteriorate.

A deficiency in internal control over financial reporting exists when
the design or operation of a control does not allow management or
employees, in the normal course of performing their assigned
functions, to prevent or detect misstatements on a timely basis. A
material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a
reasonable possibility that a material misstatement of the funds
annual or interim financial statements will not be prevented or
detected on a timely basis.

Our consideration of the Funds internal control over financial
reporting was for the limited purpose described in the first paragraph
and would not necessarily disclose all deficiencies in internal control
that might be material weaknesses under standards established by the
Public Company Accounting Oversight Board (United States).
However, we noted no deficiencies in the Funds internal control
over financial reporting and its operation, including controls over
safeguarding securities that we consider to be a material weakness as
defined above as of May 31, 2013.

This report is intended solely for the information and use of
management and the Board of Trustees of the Funds and the
Securities and Exchange Commission and is not intended to be and
should not be used by anyone other than these specified parties.



                 /s/ Ernst & Young LLP

Chicago, Illinois
July 25, 2013

Exhibit A

Fund
Nuveen Connecticut Premium Income Municipal Fund (NTC)
Nuveen Massachusetts Premium Income Municipal Fund (NMT)
Nuveen Massachusetts Dividend Advantage Municipal Fund (NMB)
Nuveen Massachusetts AMT-Free Municipal Income Fund (NGX)
Nuveen Georgia Dividend Advantage Municipal Fund 2(NKG)
Nuveen Maryland Premium Income Municipal Fund (NMY)
Nuveen Missouri Premium Income Municipal Fund (NOM)
Nuveen North Carolina Premium Income Municipal Fund (NNC)
Nuveen Virginia Premium Income Municipal Fund (NPV)
Nuveen Intermediate Duration Municipal Term Fund (NID)
Nuveen Intermediate Duration Quality Municipal Term Fund (NIQ)

EX-99.77C VOTES

Form N-SAR, Sub-Item 77C
Submission of matters to a vote of security holders


Nuveen Massachusetts Premium Income Municipal Fund
811-07486


The annual meeting of shareholders was held in the
offices of Nuveen Investments on November 14, 2012;
at this meeting the shareholders were asked to vote on
the election of Board Members, the elimination of
Fundamental Investment Policies and the approval of
new Fundamental Investment Policies. The meeting
was subsequently adjourned to December 14, 2012,
January 24, 2013, February 22, 2013 and March 14,
2013.


Voting results for the meeting are as follows:


 Common and Preferred Shares voting
 together as a class
  Preferred
Shares
To approve the elimination of the
fundamental policies relating to the Funds
 ability to make loans.


   For
            4,003,887
            1,494,536
   Against
               331,569
                 99,785
   Abstain
               132,140
                 33,355
   Broker Non-Votes
            1,971,893
            1,150,878
      Total
            6,439,489
            2,778,554



To approve the new fundamental policy
relating to the Funds ability to make
loans.


   For
            3,960,633
            1,480,426
   Against
               367,148
               109,785
   Abstain
               139,815
                 37,465
   Broker Non-Votes
            1,971,893
            1,150,878
      Total
            6,439,489
            2,778,554



Proxy materials for the annual meeting are herein
incorporated by reference
to the SEC filing on October 16, 2012, under
Conformed Submission Type DEF 14A, accession
number 0000950123-12-424609.